Nalaganje...
Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
BACKGROUND: Gait impairments are common in patients with Alzheimer’s disease. Cholinesterase inhibitors are used to treat the symptoms of patients with Alzheimer’s disease, but they have not been shown to reduce the severity of Alzheimer’s disease-related gait disorders. METHODS: This was a prospect...
Shranjeno v:
| izdano v: | BMC Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874473/ https://ncbi.nlm.nih.gov/pubmed/33568083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02098-8 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|